These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 30726680)

  • 1. Next-Generation Compound Delivery Platforms to Support Miniaturized Biology.
    Bhatt S; Crimmin S; Gross J; Nixon E; Truong M; Weglos M; Kallal L
    SLAS Technol; 2019 Jun; 24(3):245-255. PubMed ID: 30726680
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Advances in microfluidics for drug discovery.
    Lombardi D; Dittrich PS
    Expert Opin Drug Discov; 2010 Nov; 5(11):1081-94. PubMed ID: 22827746
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Primary cells and stem cells in drug discovery: emerging tools for high-throughput screening.
    Eglen R; Reisine T
    Assay Drug Dev Technol; 2011 Apr; 9(2):108-24. PubMed ID: 21186936
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Advancements in Assay Technologies and Strategies to Enable Drug Discovery.
    Busby SA; Carbonneau S; Concannon J; Dumelin CE; Lee Y; Numao S; Renaud N; Smith TM; Auld DS
    ACS Chem Biol; 2020 Oct; 15(10):2636-2648. PubMed ID: 32880443
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-throughput cellular microarray platforms: applications in drug discovery, toxicology and stem cell research.
    Fernandes TG; Diogo MM; Clark DS; Dordick JS; Cabral JM
    Trends Biotechnol; 2009 Jun; 27(6):342-9. PubMed ID: 19398140
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Emerging platforms for high-throughput enzymatic bioassays.
    Shao F; Lee PW; Li H; Hsieh K; Wang TH
    Trends Biotechnol; 2023 Jan; 41(1):120-133. PubMed ID: 35863950
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Microfluidic cell chips for high-throughput drug screening.
    Chi CW; Ahmed AR; Dereli-Korkut Z; Wang S
    Bioanalysis; 2016 May; 8(9):921-37. PubMed ID: 27071838
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The latest advances in high content screening in microfluidic devices.
    Liu W; Wang J; Qi H; Jiao Q; Wu L; Wang Y; Liang Q
    Expert Opin Drug Discov; 2023 Jul; 18(7):781-795. PubMed ID: 37219918
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of new technologies for cellular screening along the drug value chain.
    Möller C; Slack M
    Drug Discov Today; 2010 May; 15(9-10):384-90. PubMed ID: 20206290
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Towards the miniaturization of GPCR-based live-cell screening assays.
    Martins SA; Trabuco JR; Monteiro GA; Chu V; Conde JP; Prazeres DM
    Trends Biotechnol; 2012 Nov; 30(11):566-74. PubMed ID: 22921755
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Emerging Role of Neuronal Organoid Models in Drug Discovery: Potential Applications and Hurdles to Implementation.
    Struzyna LA; Watt ML
    Mol Pharmacol; 2021 Apr; 99(4):256-265. PubMed ID: 33547249
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lab-on-a-chip technologies for stem cell analysis.
    Ertl P; Sticker D; Charwat V; Kasper C; Lepperdinger G
    Trends Biotechnol; 2014 May; 32(5):245-53. PubMed ID: 24726257
    [TBL] [Abstract][Full Text] [Related]  

  • 13. On-chip investigation of cell-drug interactions.
    Zheng XT; Yu L; Li P; Dong H; Wang Y; Liu Y; Li CM
    Adv Drug Deliv Rev; 2013 Nov; 65(11-12):1556-74. PubMed ID: 23428898
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Convergence of Stem Cell Technologies and Phenotypic Drug Discovery.
    Friese A; Ursu A; Hochheimer A; Schöler HR; Waldmann H; Bruder JM
    Cell Chem Biol; 2019 Aug; 26(8):1050-1066. PubMed ID: 31231030
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-content screening in microfluidic devices.
    Cheong R; Paliwal S; Levchenko A
    Expert Opin Drug Discov; 2010 Aug; 5(8):715-20. PubMed ID: 21852997
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Academic collaborative models fostering the translation of physiological in vitro systems from basic research into drug discovery.
    Silvestri A; Vicente F; Vicent MJ; Stechmann B; Fecke W
    Drug Discov Today; 2021 Jun; 26(6):1369-1381. PubMed ID: 33677144
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Droplet microarray platforms for high-throughput drug screening.
    Shi L; Liu S; Li X; Huang X; Luo H; Bai Q; Li Z; Wang L; Du X; Jiang C; Liu S; Li C
    Mikrochim Acta; 2023 Jun; 190(7):260. PubMed ID: 37318602
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biomimetic cardiovascular platforms for in vitro disease modeling and therapeutic validation.
    Portillo-Lara R; Spencer AR; Walker BW; Shirzaei Sani E; Annabi N
    Biomaterials; 2019 Apr; 198():78-94. PubMed ID: 30201502
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Advances of droplet-based microfluidics in drug discovery.
    Wang Y; Chen Z; Bian F; Shang L; Zhu K; Zhao Y
    Expert Opin Drug Discov; 2020 Aug; 15(8):969-979. PubMed ID: 32352844
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of the Droplet-Microarray Platform for High-Throughput Screening of Suspension Cells.
    Popova AA; Depew C; Permana KM; Trubitsyn A; Peravali R; Ordiano JÁ; Reischl M; Levkin PA
    SLAS Technol; 2017 Apr; 22(2):163-175. PubMed ID: 28095175
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.